RPS6KA3 and acute myeloid leukemia: In the present study, RSK1, but not RSK2, was decreased by inhibition of FLT3-ITD in MV4-11 and primary AML cells, while inhibition of PIM did not show any effect on expression level of RSK1 or RSK2 in these cells (Figure 3G).